Publication | Open Access
Role of Matrix β-1,3 Glucan in Antifungal Resistance of Non-albicans Candida Biofilms
100
Citations
20
References
2013
Year
Biofilm MatrixMicrobial PathogensClinical MycologyAntimicrobial ChemotherapyDrug ResistanceMatrix β-1,3 GlucanAntimicrobial TherapyAntibacterial MechanismsAntimicrobial ResistanceHealth SciencesCandida Biofilm InfectionsAntimicrobial Drug DiscoveryDrug Resistance AnalysisAntifungal AgentsAntimicrobial CompoundPharmacologyClinical MicrobiologyAntifungal ResistanceAntifungal AgentAntibioticsNon-albicans Candida BiofilmsMicrobiologyAntimicrobial PharmacodynamicsMedicine
Candida biofilm infections pose an increasing threat in the health care setting due to the drug resistance associated with this lifestyle. Several mechanisms underlie the resistance phenomenon. In Candida albicans, one mechanism involves drug impedance by the biofilm matrix linked to β-1,3 glucan. Here, we show this is important for other Candida spp. We identified β-1,3 glucan in the matrix, found that the matrix sequesters antifungal drug, and enhanced antifungal susceptibility with matrix β-1,3 glucan hydrolysis.
| Year | Citations | |
|---|---|---|
Page 1
Page 1